Yukako Ito - Search Results

Year	Number of Results
2004	2
2005	6
2006	8
2007	4
2008	6
2009	4
2010	9
2011	11
2012	8
2013	7
2014	5
2015	3
2016	8
2017	6
2018	4
2019	4
2020	10
2021	5
2022	3
2023	5
2024	2

1

Application of Pharmacometrics of 5-Fluorouracil to Personalized Medicine: A Tool for Predicting Pharmacokinetic-Pharmacodynamic/Toxicodynamic Responses.

Kobuchi S, Ito Y. Kobuchi S, et al. Among authors: ito y. Anticancer Res. 2020 Dec;40(12):6585-6597. doi: 10.21873/anticanres.14683. Epub 2020 Dec 7. Anticancer Res. 2020. PMID: 33288553 Review.

2

Dissolving Microneedles as Skin Allergy Test Device.

Ito Y, Matsumoto K, Osakama N, Yoshioka R, Kobuchi S, Sakaeda T, Takada K. Ito Y, et al. Biol Pharm Bull. 2017;40(4):531-534. doi: 10.1248/bpb.b16-00768. Biol Pharm Bull. 2017. PMID: 28381808 Free article.

3

Circadian variations in the pharmacokinetics of capecitabine and its metabolites in rats.

Kobuchi S, Yazaki Y, Ito Y, Sakaeda T. Kobuchi S, et al. Among authors: ito y. Eur J Pharm Sci. 2018 Jan 15;112:152-158. doi: 10.1016/j.ejps.2017.11.021. Epub 2017 Nov 23. Eur J Pharm Sci. 2018. PMID: 29175408

4

Children's Diet and Nutrition in the Aftermath of the Torrential Rain Disaster in Western Japan: An Evaluation of Support Activities by Dietitians to Alleviate Mothers' Anxieties.

Ito Y, Tsuboyama-Kasaoka N, Nakatani H. Ito Y, et al. Disaster Med Public Health Prep. 2023 Aug 29;17:e500. doi: 10.1017/dmp.2023.158. Disaster Med Public Health Prep. 2023. PMID: 37642174

5

Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant Staphylococcus aureus agents using a rat model of sepsis.

Kobuchi S, Kanda N, Okumi T, Kano Y, Tachi H, Ito Y, Sakaeda T. Kobuchi S, et al. Among authors: ito y. Xenobiotica. 2022 Jun;52(6):583-590. doi: 10.1080/00498254.2022.2098201. Epub 2022 Sep 8. Xenobiotica. 2022. PMID: 35815433

6

Assessment of Drug-drug Interaction and Optimization in Capecitabine and Irinotecan Combination Regimen using a Physiologically Based Pharmacokinetic Model.

Sakai S, Kobuchi S, Ito Y, Sakaeda T. Sakai S, et al. Among authors: ito y. J Pharm Sci. 2022 May;111(5):1522-1530. doi: 10.1016/j.xphs.2021.12.021. Epub 2021 Dec 26. J Pharm Sci. 2022. PMID: 34965386

7

Predictive marker for exposure-driven haematological toxicity of tegafur-uracil and proposed modified-dosage regimen by pharmacometric approach in rats.

Kobuchi S, Matsui M, Ito Y. Kobuchi S, et al. Among authors: ito y. Xenobiotica. 2022 Jul;52(7):697-706. doi: 10.1080/00498254.2022.2142696. Epub 2022 Nov 22. Xenobiotica. 2022. PMID: 36412205

8

Transport of Azithromycin into Extravascular Space in Rats.

Kobuchi S, Aoki M, Inoue C, Murakami H, Kuwahara A, Nakamura T, Yasui H, Ito Y, Takada K, Sakaeda T. Kobuchi S, et al. Among authors: ito y. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6823-6827. doi: 10.1128/AAC.01570-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27600045 Free PMC article.

9

Population Pharmacokinetic Model-Based Evaluation of Intact Oxaliplatin in Rats with Acute Kidney Injury.

Kobuchi S, Kai M, Ito Y. Kobuchi S, et al. Among authors: ito y. Cancers (Basel). 2021 Dec 20;13(24):6382. doi: 10.3390/cancers13246382. Cancers (Basel). 2021. PMID: 34945005 Free PMC article.

10

A validated LC-MS/MS method for the low-level determination of pemafibrate, a novel SPPARMα, in plasma.

Kobuchi S, Shigemura A, Ito Y, Sakaeda T. Kobuchi S, et al. Among authors: ito y. Bioanalysis. 2020 May;12(10):683-692. doi: 10.4155/bio-2020-0081. Epub 2020 Jun 3. Bioanalysis. 2020. PMID: 32489112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

99 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year